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Bipolar disorders: from remission to maintenance
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The management of bipolar disorder has traditionally
focused upon the treatment of acute mania and although
this is a fundamental aspect of patients' care, other aspects
of mood stabilisation, e.g. treatment of depression, have
been overshadowed. Most of the problems come when
decisions are based only on the potential efficacy of treat-
ments, rather than effectiveness. Efficacy responds to the
question: Does a treatment work under ideal conditions?,
whereas effectiveness responds to the question: Does a
treatment work under the conditions of routine care?. The
answer to the second question should be more relevant to
clinicians. Moreover, in the past decade we have learned
that beyond improvement and short-term response, we
have to design our therapies to achieve remission and
maintain it successfully, which means recovery.
Indeed, the mood-stabilising agent lithium, introduced in
1949 as a treatment for mania is the mainstay of long-
term treatment of bipolar disorder and is in widespread
clinical use. However, lithium has a slow onset of action
and is not very well tolerated, so despite its efficacy, effec-
tiveness is quite low. Of those patients with bipolar disor-
der who receive treatment, poor adherence with
medication is a significant problem. When associated
with lithium treatment in particular, poor adherence
increases the risk of relapse. The need for well-tolerated
agents with efficacy in depression as well as mania, has led
researchers to evaluate the potential of a variety of anti-
convulsants, antidepressants and antipsychotics as pri-
mary or adjunctive, which have proved to be efficacious
and generally safer than the older drugs. Besides lithium
and traditional anticonvulsants, the atypical antipsychot-
ics, novel anticonvulsants, and psychoeducational
approaches are effective new tools for the treatment of
bipolar illness. All them should be reasonably combined
in treatment regimens aimed at achieving not only remis-
sion of acute episodes, but long-term recovery.
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